文献速递功能神经外科

基于直线加速器的三叉神经痛放射外科治疗:头架固定与面罩固定技术的疗效比较

Linear accelerator-based radiosurgery for trigeminal neuralgia: comparative outcomes of frame-based and mask-based techniques.
PubMed 文献 · J Neurosurg · 2021-11-26

该回顾性研究比较了1996至2019年间234例三叉神经痛患者接受头架固定5mm准直器与面罩固定4mm准直器放射外科治疗的结局。头架5mm组初始及≥24个月疼痛控制率均高于面罩4mm组,且面罩组疼痛复发更早更频繁,两组新发永久性面部感觉减退无显著关联。作者认为头架5mm准直器放射外科长期疼痛缓解更优且毒性相似。

要点

  • 头架5mm组初始疼痛控制率93.4%,面罩4mm组87.6%;≥24个月分别为89.9%和77.8%。
  • 面罩4mm组疼痛复发中位时间12个月短于头架5mm组29个月(p=0.016),复发率38.1% vs 20.4%(p=0.003)。
  • 新发永久性面部感觉减退总发生率30.3%,头架5mm组33.6% vs 面罩4mm组25.8%,与BNI面部感觉减退评分无显著关联。

核心结论

  • 头架固定5mm准直器放射外科治疗三叉神经痛较面罩固定4mm准直器获得更好的长期疼痛缓解,且毒性特征相似。

研究设计与样本

  • 回顾性综述1996年至2019年在本机构接受放射外科治疗的三叉神经痛患者,共纳入234例,平均年龄67岁。

主要发现

  • 头架5mm组(137例,58.5%)初始充分疼痛控制率(BNI I-III)93.4%,面罩4mm组(97例,41.5%)87.6%。
  • ≥24个月充分疼痛控制率头架5mm组89.9%,面罩4mm组77.8%;从初始反应至末次随访(≥24个月)两组疼痛缓解差异显著(p=0.02)。
  • 新发永久性面部感觉减退总发生率30.3%,头架5mm组33.6%,面罩4mm组25.8%;BNI面部感觉减退评分与分组无显著关联。
  • 面罩4mm组较头架5mm组疼痛复发更早(中位复发时间12个月 vs 29个月,p=0.016)且更频繁(38.1% vs 20.4%,p=0.003)。

临床怎么用

  • 作者认为头架固定5mm准直器放射外科治疗三叉神经痛可获得更好的长期疼痛缓解,且毒性特征与面罩固定4mm准直器相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Precise and accurate targeting is critical to optimize outcomes after stereotactic radiosurgery (SRS) for trigeminal neuralgia (TN). The aim of this study was to compare the outcomes after SRS for TN in which two different techniques were used: mask-based 4-mm cone versus frame-based 5-mm cone. METHODS: The authors performed a retrospective review of patients who underwent SRS for TN at their institution between 1996 and 2019. The Barrow Neurological Institute (BNI) pain score and facial hypesthesia scale were used to evaluate pain relief and facial numbness. RESULTS: A total of 234 patients were included in this study; the mean age was 67 years. In 97 patients (41.5%) radiation was collimated by a mask-based 4-mm cone, whereas a frame-based 5-mm cone was used in the remaining 137 patients (58.5%). The initial adequate pain control rate (BNI I-III) was 93.4% in the frame-based 5-mm group, compared to 87.6% in the mask-based 4-mm group. This difference between groups lasted, with an adequate pain control rate at ≥ 24 months of 89.9% and 77.8%, respectively. Pain relief was significantly different between groups from initial response until the last follow-up (≥ 24 months, p = 0.02). A new, permanent facial hypesthesia occurred in 30.3% of patients (33.6% in the frame-based 5-mm group vs 25.8% in the mask-based 4-mm group). However, no significant association between the BNI facial hypesthesia score and groups was found. Pain recurrence occurred earlier (median time to recurrence 12 months vs 29 months, p = 0.016) and more frequently (38.1% vs 20.4%, p = 0.003) in the mask-based 4-mm than in the frame-based 5-mm group. CONCLUSIONS: Frame-based 5-mm collimator SRS for TN resulted in a better long-term pain relief with similar toxicity profiles to that seen with mask-based 4-mm collimator SRS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kienzler JC, Tenn S, Chivukula S, et al. Linear accelerator-based radiosurgery for trigeminal neuralgia: comparative outcomes of frame-based and mask-based techniques. J Neurosurg. 2021. PMID: 34826815. doi:10.3171/2021.8.JNS21658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。